• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解读罗马尼亚医用氧气市场的主要特点与前景

Shedding Light on the Main Characteristics and Perspectives of Romanian Medicinal Oxygen Market.

作者信息

Davidescu Adriana AnaMaria, Apostu Simona Andreea, Stanciu-Mandruleanu Cristina

机构信息

Department of Statistics and Econometrics, Bucharest University of Economic Studies, Bucharest 010374, Romania.

Labour Market Policies Department, National Scientific Research Institute for Labour and Social Protection, Bucharest 061643, Romania.

出版信息

Healthcare (Basel). 2021 Feb 3;9(2):155. doi: 10.3390/healthcare9020155.

DOI:10.3390/healthcare9020155
PMID:33546111
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7913192/
Abstract

Medicinal oxygen plays an important role in healthcare, being essential for the existence and maintenance of the health of millions of people, who depend on medicinal oxygen every day, both in hospitals and at home. Medicinal oxygen is the primary treatment administrated to the majority of patients suffering from respiratory problems and low levels of oxygen in the blood, and in the context of the actual health crisis caused by the new COVID-19, the challenge is represented by increasing the supply of medicinal oxygen while reducing cost so that it is accessible where it is needed most, free at the point of use. It will take increased investment and commitment to put oxygen at the center of strategies for universal health coverage. In this context, it becomes essential to investigate the main characteristics of the Romanian market of medicinal oxygen, highlighting top key players, market development, key driving factors, types of products, market perspectives as well as shedding light on the segmentation of this particular market based on considerations regarding regions, hospital competence class and hospital specialization. Also, the research aims to explore the regional disparities in the decision of using O93%medicinal oxygen, revealing the main factors related to the usage of this type of product among Romanian public hospitals. The research relies on the first quantitative survey regarding medicinal oxygen usage among 121 public hospital units from a total of 461 public hospitals in 2018, which meet the specific requirements: includes the entire population according to the list published on the website of the Ministry of Health, is the most recent data and does not show repetition. The sampling was of probabilistic stage-type stratification, with the following sampling layers: hospital county distribution, hospital competence class officially assigned by the Ministry of Health and also area of residence (urban/rural). In order to analyze the main characteristics of the Romanian oxygen market, the following methods have been used: analysis of variance (ANOVA) together with Kruskal-Wallis, Pearson correlation coefficient as well as Goodman and Kruskal gamma, Kendall's tau-b and Cramer's V, as well as multilevel logistic regression analysis using hierarchical data (hospitals grouped in regions). The Romanian market of medicinal oxygen is rather an oligopoly market characterized by the existence of a small number of producers and two types of products currently used for the same medical purpose and having a substitutable character: medicinal oxygen O99.5%, and medicinal oxygen O93%. An overwhelming proportion of public hospitals agree that both types of medicinal oxygen serve the same therapeutic purpose. The Romanian market of medicinal oxygen highlighted a significant segmentation on considerations based on regions, hospital competence class and hospital specialization. Regarding the main perspectives, the Romanian market of medical oxygen keeps the growth trend registered globally, with development perspectives for competitors. Exploring the regional disparities in the decision of using O93 medicinal oxygen, the empirical results acknowledged the important role of unitary price, hospital capacity and the relevance of this product seen as a medicine. Medicinal oxygen is vital in sustaining life, proving its utility mainly in the context of the actual health crisis. In this context, the Romanian local market exhibits prospects for further development, being characterized by an important segmentation depending on regions, hospital competence class and hospital specialization.

摘要

医用氧气在医疗保健中发挥着重要作用,对数百万民众的健康生存和维持至关重要,这些人无论在医院还是在家中,每天都依赖医用氧气。医用氧气是大多数患有呼吸问题和血液中氧气含量低的患者接受的主要治疗手段,在新型冠状病毒引发的当前健康危机背景下,挑战在于增加医用氧气供应的同时降低成本,以便在最需要的地方能够获得,且使用时免费。需要增加投资并做出承诺,将氧气置于全民健康覆盖战略的核心位置。在这种背景下,调查罗马尼亚医用氧气市场的主要特征变得至关重要,包括突出主要关键参与者、市场发展、关键驱动因素、产品类型、市场前景,以及基于地区、医院资质等级和医院专科等因素对这一特定市场进行细分。此外,该研究旨在探索在使用O93%医用氧气决策方面的地区差异,揭示罗马尼亚公立医院中与这类产品使用相关的主要因素。该研究基于2018年对461家公立医院中的121家公立医院单位进行的关于医用氧气使用情况的首次定量调查,这些医院符合特定要求:根据卫生部网站公布的名单涵盖了全部人口,是最新数据且无重复。抽样采用概率阶段式分层,有以下抽样层次:医院所在县分布、卫生部正式指定的医院资质等级以及居住地区(城市/农村)。为了分析罗马尼亚氧气市场的主要特征,使用了以下方法:方差分析(ANOVA)以及克鲁斯卡尔 - 沃利斯检验、皮尔逊相关系数以及古德曼和克鲁斯卡尔伽马系数、肯德尔tau - b系数和克莱默V系数,以及使用分层数据(按地区分组的医院)的多级逻辑回归分析。罗马尼亚医用氧气市场相当于是一个寡头垄断市场,其特点是生产者数量少以及目前用于相同医疗目的且具有可替代性的两种产品:O99.5%医用氧气和O93%医用氧气。绝大多数公立医院认为这两种医用氧气具有相同的治疗目的。罗马尼亚医用氧气市场在基于地区、医院资质等级和医院专科等因素方面存在显著细分。关于主要前景,罗马尼亚医用氧气市场保持着全球范围内的增长趋势,对竞争对手而言具有发展前景。在探索使用O93医用氧气决策方面的地区差异时,实证结果认可了单价、医院规模以及该产品作为药品的相关性所起的重要作用。医用氧气对维持生命至关重要,在当前健康危机背景下证明了其效用。在此背景下,罗马尼亚本地市场展现出进一步发展的前景,其特点是根据地区、医院资质等级和医院专科存在重要细分。

相似文献

1
Shedding Light on the Main Characteristics and Perspectives of Romanian Medicinal Oxygen Market.解读罗马尼亚医用氧气市场的主要特点与前景
Healthcare (Basel). 2021 Feb 3;9(2):155. doi: 10.3390/healthcare9020155.
2
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.在流行地区,服用抗叶酸抗疟药物的人群中,叶酸补充剂与疟疾易感性和严重程度的关系。
Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217.
3
Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial.评估 BIO101 预防 COVID-19 肺炎患者呼吸恶化的疗效和安全性(COVA 研究):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Jan 11;22(1):42. doi: 10.1186/s13063-020-04998-5.
4
Japan as the front-runner of super-aged societies: Perspectives from medicine and medical care in Japan.日本作为超老龄化社会的领跑者:来自日本医学与医疗护理的视角
Geriatr Gerontol Int. 2015 Jun;15(6):673-87. doi: 10.1111/ggi.12450. Epub 2015 Feb 5.
5
The Minderoo-Monaco Commission on Plastics and Human Health.美诺集团-摩纳哥基金会塑料与人体健康委员会
Ann Glob Health. 2023 Mar 21;89(1):23. doi: 10.5334/aogh.4056. eCollection 2023.
6
[Early achievements of the Danish pharmaceutical industry--8. Lundbeck].[丹麦制药行业的早期成就——8. 灵北公司]
Theriaca. 2016(43):9-61.
7
Effect of dexamethasone in patients with ARDS and COVID-19 - prospective, multi-centre, open-label, parallel-group, randomised controlled trial (REMED trial): A structured summary of a study protocol for a randomised controlled trial.地塞米松治疗 ARDS 合并 COVID-19 患者的效果 - 一项前瞻性、多中心、开放标签、平行组、随机对照试验(REMED 试验):一项随机对照试验研究方案的结构化总结。
Trials. 2021 Mar 1;22(1):172. doi: 10.1186/s13063-021-05116-9.
8
The intervention of local public authorities and the impact of the COVID-19 pandemic in Romania: a subnational analysis.罗马尼亚地方公共当局的干预措施和 COVID-19 大流行的影响:国家以下层面的分析。
Front Public Health. 2024 May 16;12:1105518. doi: 10.3389/fpubh.2024.1105518. eCollection 2024.
9
Safety and Efficacy of Imatinib for Hospitalized Adults with COVID-19: A structured summary of a study protocol for a randomised controlled trial.COVID-19 住院成人患者使用伊马替尼的安全性和疗效:一项随机对照试验研究方案的结构化总结。
Trials. 2020 Oct 28;21(1):897. doi: 10.1186/s13063-020-04819-9.
10
New ways of insulin delivery.胰岛素递送的新方法。
Int J Clin Pract Suppl. 2010 Feb(166):29-40. doi: 10.1111/j.1742-1241.2009.02276.x.

本文引用的文献

1
Oxygen therapy for acutely ill medical patients: a clinical practice guideline.急性病内科患者的氧疗:临床实践指南
BMJ. 2018 Oct 24;363:k4169. doi: 10.1136/bmj.k4169.
2
Oxygen for children and newborns in non-tertiary hospitals in South-west Nigeria: A needs assessment.尼日利亚西南部非三级医院儿童及新生儿用氧:需求评估
Afr J Med Med Sci. 2016 May;45(1):31-49.
3
Oxygen Availability and Nursing Capacity for Oxygen Therapy in Ugandan Paediatric Wards.乌干达儿科病房的氧气供应及氧气治疗护理能力
J Trop Pediatr. 2018 Apr 1;64(2):97-103. doi: 10.1093/tropej/fmx033.
4
Providing oxygen to children in hospitals: a realist review.为医院中的儿童提供氧气:一项现实主义综述。
Bull World Health Organ. 2017 Apr 1;95(4):288-302. doi: 10.2471/BLT.16.186676. Epub 2017 Feb 21.
5
Be rich or don't be sick: estimating Vietnamese patients' risk of falling into destitution.要么富有,要么不得病:评估越南患者陷入贫困的风险。
Springerplus. 2015 Sep 21;4:529. doi: 10.1186/s40064-015-1279-x. eCollection 2015.
6
Using the WHO essential medicines list to assess the appropriateness of insurance coverage decisions: a case study of the Croatian national medicine reimbursement list.利用世界卫生组织基本药物清单评估保险覆盖范围决策的适宜性:克罗地亚国家药物报销清单的案例研究
PLoS One. 2014 Oct 22;9(10):e111474. doi: 10.1371/journal.pone.0111474. eCollection 2014.
7
Oxygen 93: a new option for European hospitals.
Br J Anaesth. 2014 Nov;113(5):886-7. doi: 10.1093/bja/aeu359.
8
Moving toward universal coverage of health insurance in Vietnam: barriers, facilitating factors, and lessons from Korea.越南迈向全民医疗保险覆盖:障碍、促进因素及韩国的经验教训
J Korean Med Sci. 2014 Jul;29(7):919-25. doi: 10.3346/jkms.2014.29.7.919. Epub 2014 Jul 11.
9
The potential harm of oxygen therapy in medical emergencies.医疗急救中氧疗的潜在危害。
Crit Care. 2013 Apr 18;17(2):313. doi: 10.1186/cc12554.
10
Multicenter study of hypoxemia prevalence and quality of oxygen treatment for hospitalized Malawian children.多中心研究马拉维住院儿童低氧血症的患病率和氧疗质量。
Trans R Soc Trop Med Hyg. 2013 May;107(5):285-92. doi: 10.1093/trstmh/trt017.